To help accelerate the development of treatments for Alzheimer’s disease, the Alzheimer’s Association’s Part the Cloud research grant program is investing $24 million in clinical trials investigating 16 potential therapies. Scientists from around the world will use the funds to conduct Phase 1 and 2 trials testing a variety of experimental medications and devices. The studies involve prospective treatments that focus on how brain cells use energy and fuel, and how they extract waste and debris…
You must be logged in to read/download the full post.
The post Part the Cloud Awards $24M to Researchers Studying Potential Alzheimer’s Treatments appeared first on BioNewsFeeds.